TipRanks
Paradigm Biopharmaceuticals Ltd. (PBIGF)
OTHER OTC:PBIGF
US Market
PBIGF
Paradigm Biopharmaceuticals
RESEARCH TOOLSreports

Paradigm Biopharmaceuticals (PBIGF) Income Statement

17 Followers

Paradigm Biopharmaceuticals Income Statement

Last quarter (Q4 2026), Paradigm Biopharmaceuticals's total revenue was AU$55.00K, a decrease of -16.41% from the same quarter last year. In Q4, Paradigm Biopharmaceuticals's net income was AU$-33.09M. See Paradigm Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 80.15KAU$ 52.12KAU$ 65.80KAU$ 46.76KAU$ 79.22K
Gross Profit
AU$ -82.37KAU$ -19.89KAU$ 56.81KAU$ -18.83KAU$ -64.53K
Operating Expenses
AU$ 61.03MAU$ 22.87MAU$ 65.10MAU$ 60.07MAU$ 47.93M
Depreciation and Amortization
AU$ 150.39KAU$ 51.42KAU$ 146.74KAU$ 153.66KAU$ 193.25K
EBITDA
AU$ -60.96MAU$ -25.25MAU$ -64.54MAU$ -59.06MAU$ -46.82M
Operating Income
AU$ -61.11MAU$ -22.89MAU$ -65.19MAU$ -59.22MAU$ -47.01M
Other Income/Expenses
AU$ -2.84MAU$ -2.42MAU$ 6.54MAU$ 263.61KAU$ -1.48K
Pretax Income
AU$ -63.95MAU$ -25.30MAU$ -58.65MAU$ -58.95MAU$ -47.01M
Net Income
AU$ -56.33MAU$ -18.77MAU$ -58.65MAU$ -51.91MAU$ -39.25M
Per Share Metrics
Basic EPS
AU$ -0.15AU$ -0.06AU$ -0.20AU$ -0.18AU$ -0.16
Diluted EPS
AU$ -0.15AU$ -0.06AU$ -0.20AU$ -0.18AU$ -0.16
Weighted Average Shares Outstanding
 370.03M 314.50M 293.28M 289.68M 240.96M
Weighted Average Shares Outstanding (Diluted)
 370.03M 314.50M 293.28M 289.68M 241.82M
Currency in AUD

Paradigm Biopharmaceuticals Earnings and Revenue History